The impact of cigarette/e-cigarette vapour on simulated pulmonary surfactant monolayers under physiologically relevant conditions

Surface and Interface Analysis

Volumn 49, Issue 7, 2017, Pages 654-665

  Davies, Michael J ^a   Birkett, Jason W ^a   Kotwa, Mateusz ^a   Tomlinson, Lauren ^a   Woldetinsae, Rezene ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

cigarettes; e cigarettes; gas chromatography; Langmuir monolayers; lung biosimulator; pulmonary surfactant; smoking

Indexed keywords

BIOLOGICAL ORGANS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; COPYRIGHTS; GAS CHROMATOGRAPHY; MONOLAYERS; NICOTINE; PHOSPHOLIPIDS; TOBACCO;

CIGARETTES; LANGMUIR MONOLAYERS; LUNG BIOSIMULATOR; PULMONARY SURFACTANTS; SMOKING;

SURFACE ACTIVE AGENTS;

EID: 85020127636     PISSN: 01422421     EISSN: 10969918     Source Type: Journal    
DOI: 10.1002/sia.6205     Document Type: Article

References (50)

1. J. Scott, The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development, Tob Induced Dis, 2004, 2(1), 1.
2. P. Nahak, K. Nag, A. Hillier, R. Devraj, D. Thompson, K. Manna, K. Makino, H. Ohshima, H. Nakahara, O. Shibata, A. K. Panda, Effect of serum, cholesterol and low density lipoprotein on the functionality and structure of lung surfactant films, J. Oleo Sci., 2014, 63(12), 1333–1349.
3. E. Keating, L. Rahman, J. Francis, A. Petersen, F. Possmayer, R. Veldhuizen, N. O. Petersen, Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant, Biophys. J., 2007, 93(4), 1391–1401.
4. M. Davies, A. Brindley, X. Chen, S. Doughty, M. Marlow, C. Roberts, A quantitative assessment of inhaled drug particle–pulmonary surfactant interaction by atomic force microscopy, Colloids Surf. B Biointerfaces, 2009, 73(1), 97–102.
5. J. Ward, J. Ward, R. M. Leach, The Respiratory System at a Glance, John Wiley & Sons, Singapore, Hoboken, 2011.
6. Eastwood P. Statistics on smoking – England. Health and Social Care Information Centre. 2012.
7. M. J. Davies, T. Kerry, L. Seton, M. Murphy, P. Gibbons, J. Khoo, M. Naderi, The crystal engineering of salbutamol sulphate via simulated pulmonary surfactant monolayers, Int. J. Pharm., 2013, 446(1–2), 34–45.
8. J. Zasadzinski, J. Ding, H. Warriner, F. Bringezu, A. Waring, The physics and physiology of lung surfactants, Curr. Opin. Colloid Interface Sci., 2001, 6(5–6), 506–513.
9. E. Parra, J. Pérez-Gil, Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films, Chem. Phys. Lipids, 2015, 185, 153–175.
10. A. Lotze, Survanta® Pre-ecmo Trial: Multicenter evaluation of Survanta® in treatment of term infants with severe respiratory failure. 1341, Pediatr. Res., 1996, 39, 226–226.
11. F. Bringezu, K. Pinkerton, J. Zasadzinski, Environmental tobacco smoke effects on the primary lipids of lung surfactant, Langmuir, 2003, 19(7), 2900–2907.
12. M. J. Davies, L. Seton, N. Tiernan, M. F. Murphy, P. Gibbons, Towards crystal engineering via simulated pulmonary surfactant monolayers to optimise inhaled drug delivery, Int. J. Pharm., 2011, 421, 1–11.
13. Davies M.J. International patent application: WO2014199178. Title: Device and method for simulating pulmonary environments. 2014.
14. P. Stenger, C. Alonso, J. Zasadzinski, A. Waring, C. Jung, K. Pinkerton, Environmental tobacco smoke effects on lung surfactant film organization, BBA Biomemb, 2009, 1788(2), 358–370.
15. J. Brown, R. West, E. Beard, S. Michie, L. Shahab, A. McNeill, Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers, Addict. Behav., 2014, 39(5), 1120–1125.
16. S. Uchiyama, K. Ohta, Y. Inaba, N. Kunugita, Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine, followed by high-performance liquid chromatography, Anal. Sci., 2013, 29(12), 1219–1222.
17. M. L. Goniewicz, J. Knysak, M. Gawron, L. Kosmider, A. Sobczak, J. Kurek, A. Prokopowicz, M. Jablonska-Czapla, C. Rosik-Dulewska, C. Havel, P. Jacob III, N. Benowitz, Levels of selected carcinogens and toxicants in vapour from electronic cigarettes, Tob. Control, 2014, 23(2), 133–139.
18. R. Tayyarah, G. Long, Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air, Regul. Toxicol. Pharmacol., 2014, 70(3), 704–710.
19. Health Canada. Determination of “tar”, nicotine and carbon monoxide in mainstream tobacco smoke. Tobacco Control. 1999.
20. A. R. Shah, R. Banerjee, Effect of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on surfactant monolayers, Colloids Surf. B. Biointerfaces, 2011, 85, 116–124.
21. S. Subramaniam, Biochemical and biophysical characterization of pulmonary surfactant in rats exposed chronically to cigarette smoke, Fundam. Appl. Toxicol., 1995, 27(1), 63–69.
22. Z. Khattari, U. Langer, S. Aliaskarisohi, A. Ray, M. Fischer, Effects of soluble surfactants on the Langmuir monolayers compressibility: a comparative study using interfacial isotherms and fluorescence microscopy, Mater. Sci. Eng. C, 2011, 31, 1711–1715.
23. F. Behroozi, Theory of elasticity in two dimensions and its application to langmuir–blodgett films, Langmuir, 1996, 12(9), 2289–2291.
24. M. Chan-Yeung, H. Dimich-Ward, Respiratory health effects of exposure to environmental tobacco smoke, Respirology, 2003, 8(2), 131–139.
25. E. Akbaş, E. Derici, F. Söylemez, A. Kanik, F. Polat, An investigation of effects of toluene and cigarette smoking on some blood parameters and lymphocyte life span, Cell Biol. Toxicol., 2004, 20(1), 33–40.
26. R. Kandyala, S. Raghavendra, S. Rajasekharan, Xylene: an overview of its health hazards and preventive measures, J. Oral Maxillofac. Pathol, 2010, 14(1), 1.
27. M. L. Trehy, W. Ye, M. E. Hadwiger, T. W. Moore, J. F. Allgire, J. T. Woodruff, S. S. Ahadi, J. C. Black, B. J. Westenberger, Analysis of electronic cigarette cartridges, refill solutions, and smoke for icotine and nicotine related impurities, Liq Chrom Relat 0Tech, 2011, 34(14), 1442–1458.
28. P. Vijayaraj, C. Sivaprakasam, L. Varthini, M. Sarkar, V. Nachiappan, In vitro exposure of tobacco specific nitrosamines decreases the rat lung phospholipids by enhanced phospholipase A2 activity, Toxicol. In Vitro, 2014, 28(6), 1097–1105.
29. E. K. Farsalinos, G. Romagna, E. Allifranchini, E. Ripamonti, E. Bocchietto, S. Todeschi, D. Tsiapras, S. Kyrzopoulos, V. Voudris, Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells, Int. J. Environ. Res. Public Health, 2013, 10(10), 5146–5162.
30. T. Schripp, D. Markewitz, E. Uhde, T. Salthammer, Does e-cigarette consumption cause passive vaping? Indoor Air, 2012, 23, 25–31.
31. J. Ding, D. Takamoto, A. von Nahmen, M. Lipp, K. Lee, A. Waring, J. A. Zasadzinski, Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability, Biophys. J., 2001, 80(5), 2262–2272.
32. J. Lyklema, Fundamentals of Interface and Colloid Science, III, Academic Press, London, 2000.
33. Kanisto K., Yhteiskoulu H. Effects of nicotine on a primary lipid of lung surfactant: testing the stability and efficiency using subphases of different ion strengths and pH. 2006.
34. Mayer B. Nicotine the basics. A Scientist's View about Nicotine and Tobacco. 2016.
35. Rockville M.D. How tobacco smoke causes disease. U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General. 2010.
36. G. Wang, X. Cheng, X. Li, Y. Liu, X. Wang, X. Shi, Z. Y. Wang, Y. Q. Guo, Z. S. Wen, Y. C. Huang, G. B. Zhou, Tobacco smoke induces production of chemokine CCL20 to promote lung cancer, Cancer Lett., 2015, 363(1), 60–70.
37. S. Hecht, D. Hoffmann, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke, Carcinogenesis, 1988, 9(6), 875–884.
38. K. Rodríguez-Capote, D. Manzanares, T. Haines, F. Possmayer, Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C, Biophys. J., 2006, 90(8), 2808–2821.
39. A. Von Nahmen, M. Schenk, M. Sieber, M. Amrein, The structure of a model pulmonary surfactant as revealed by scanning force microscopy, Biophys. J., 1997, 72(1), 463–469.
40. M. Soto-Arriaza, C. Sotomayor, E. Lissi, Relationship between lipid peroxidation and rigidity in L-α-phosphatidylcholine-DPPC vesicles, J. Colloid Interface Sci., 2008, 323(1), 70–74.
41. R. Notter, Lung Surfactants, Marcel Dekker, New York, 2000.
42. U. Anand, R. Agarwal, C. Anand, Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients, Chest, 1992, 101(1), 290.
43. C. Alonso, T. Alig, J. Yoon, F. Bringezu, H. Warriner, J. Zasadzinski, More than a monolayer: relating lung surfactant structure and mechanics to composition, Biophys. J., 2004, 87(6), 4188–4202.
44. A. Akella, B. S. Deshpande, Pulmonary surfactants and their role in pathophysiology of lung disorders, Indian J. Exp. Biol., 2013, 51, 5–22.
45. M. Lusuardi, A. Capelli, S. Carli, M. Tacconi, M. Salmona, C. Donner, Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications, Respiration, 1992, 59(1), 28–32.
46. G. Zetterberg, T. Curstedt, A. Eklund, A possible alteration of surfactant in broncho-alveolar lavage fluid from healthy smokers compared to non-smokers and patients with sarcoidosis, Sarcoidosis, 1995, 12, 46–50.
47. L. Kosmider, A. Sobczak, M. Fik, J. Knysak, M. Zaciera, J. Kurek, M. L. Goniewicz, Carbonyl compounds in electronic cigarette vapors - effects of nicotine solvent and battery output voltage, Nicotine Tob. Res., 2014 doi: 10.1093/ntr/ntu078.
48. A. Saffari, N. Daher, A. Ruprecht, C. De Marco, P. Pozzi, R. Boffi, S. H. Hamad, M. M. Shafer, J. J. Schauer, D. Westerdahl, C. Sioutas, Particulate metals and organic compounds from electronic and tobacco-containing cigarettes: comparison of emission rates and second-hand exposure, Evnviron. Sci. Process. Impacts, 2014, 16(10), 2259–2267.
49. M. Hua, H. Yip, P. Talbot, Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos, Tob. Control, 2011, 22 103–106.
50. G. Devendra, R. G. Spragg, Lung surfactant in subacute pulmonary disease, Respir. Res., 2002, 3(11) https://dx.doi.org/10.1186%2Frr168.